- Home
- BWFG vs IVVD Comparison
BWFG vs IVVD Comparison
Compare BWFG & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BWFG | IVVD |
|---|---|---|
| Founded | 2002 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.5M | 437.1M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BWFG | IVVD |
|---|---|---|
| Price | $51.53 | $1.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $55.00 | $8.75 |
| AVG Volume (30 Days) | 26.4K | ★ 2.8M |
| Earning Date | 04-22-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | ★ 261.79 | 79.02 |
| EPS | ★ 1.41 | N/A |
| Revenue | $2,826,000.00 | ★ $53,426,000.00 |
| Revenue This Year | $17.64 | $61.57 |
| Revenue Next Year | $6.21 | $41.42 |
| P/E Ratio | $36.46 | ★ N/A |
| Revenue Growth | 43.96 | ★ 110.47 |
| 52 Week Low | $34.20 | $0.49 |
| 52 Week High | $53.86 | $3.07 |
Technical Indicators
Market Signals| Indicator | BWFG | IVVD |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 38.12 |
| Support Level | $50.15 | $1.04 |
| Resistance Level | $53.50 | $1.14 |
| Average True Range (ATR) | 1.03 | 0.10 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 52.31 | 23.44 |
Price Performance
Historical ComparisonAbout BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.